MENU
LGVN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Longeveron (LGVN) Earnings Date & Reports
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs... Show more
A.I. Advisor
published Earnings
LGVN is expected to report earnings to fall 7.89% to -17 cents per share on August 07
Q2'26
Est.
$-0.17
Q1'26
Beat
by $0.13
Q4'25
Missed
by $0.04
Q3'25
Missed
by $0.18
Q2'25
Missed
by $0.11
The last earnings report on May 13 showed earnings per share of -18 cents, beating the estimate of -31 cents. With 70.35K shares outstanding, the current market capitalization sits at 25.59M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Details
Industry
N/A
Address
1951 NW 7th Avenue
Phone
+1 305 909-0840
Employees
38
Web
https://www.longeveron.com